448 related articles for article (PubMed ID: 17644365)
1. Influence of diaphragmatic mobility on exercise tolerance and dyspnea in patients with COPD.
Paulin E; Yamaguti WP; Chammas MC; Shibao S; Stelmach R; Cukier A; Carvalho CR
Respir Med; 2007 Oct; 101(10):2113-8. PubMed ID: 17644365
[TBL] [Abstract][Full Text] [Related]
2. [Effect of dynamic hyperinflation on exertional dyspnea, exercise performance and quality of life in COPD].
Ozgur ES; Atis S; Kanik A
Tuberk Toraks; 2008; 56(3):296-303. PubMed ID: 18932031
[TBL] [Abstract][Full Text] [Related]
3. [Cardiac autonomic responses to exercise testing in patients with chronic obstructive pulmonary disease].
Inal Ince D; Savci S; Arikan H; Sağlam M; Boşnak Güçlü M; Tokgözoğlu L; Cöplü L
Anadolu Kardiyol Derg; 2010 Apr; 10(2):104-10. PubMed ID: 20382606
[TBL] [Abstract][Full Text] [Related]
4. Peripheral arterial disease: an underestimated aetiology of exercise intolerance in chronic obstructive pulmonary disease patients.
Castagna O; Boussuges A; Nussbaum E; Marqueste L; Brisswalter J
Eur J Cardiovasc Prev Rehabil; 2008 Jun; 15(3):270-7. PubMed ID: 18446087
[TBL] [Abstract][Full Text] [Related]
5. [The importance of the at risk COPD patients (Stage 0) and clinical differences].
Kömüs N; Tertemiz KC; Sevinç C
Tuberk Toraks; 2008; 56(4):382-9. PubMed ID: 19123073
[TBL] [Abstract][Full Text] [Related]
6. [Maximal respiratory pressures and exercise tolerance in patients with COPD].
Maskey-Warzechowska M; Przybyłowski T; Hildebrand K; Wrotek K; Wiwała J; Kościuch J; Chazan R
Pneumonol Alergol Pol; 2006; 74(1):72-6. PubMed ID: 17175981
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Sit-to-Stand Test with 6 min walk test in patients with chronic obstructive pulmonary disease.
Ozalevli S; Ozden A; Itil O; Akkoclu A
Respir Med; 2007 Feb; 101(2):286-93. PubMed ID: 16806873
[TBL] [Abstract][Full Text] [Related]
8. Exercise in severe COPD: is walking different from stair-climbing?
Dreher M; Walterspacher S; Sonntag F; Prettin S; Kabitz HJ; Windisch W
Respir Med; 2008 Jun; 102(6):912-8. PubMed ID: 18280129
[TBL] [Abstract][Full Text] [Related]
9. Combined effects of obesity and chronic obstructive pulmonary disease on dyspnea and exercise tolerance.
Ora J; Laveneziana P; Ofir D; Deesomchok A; Webb KA; O'Donnell DE
Am J Respir Crit Care Med; 2009 Nov; 180(10):964-71. PubMed ID: 19897773
[TBL] [Abstract][Full Text] [Related]
10. Functional capacity in severe chronic obstructive pulmonary disease.
Inal-Ince D; Savci S; Coplu L; Arikan H
Saudi Med J; 2005 Jan; 26(1):84-9. PubMed ID: 15756359
[TBL] [Abstract][Full Text] [Related]
11. Inhaled corticosteroids as additional treatment in alpha-1-antitrypsin-deficiency-related COPD.
Corda L; Bertella E; La Piana GE; Boni E; Redolfi S; Tantucci C
Respiration; 2008; 76(1):61-8. PubMed ID: 18319586
[TBL] [Abstract][Full Text] [Related]
12. Limitations to the 6-minute walk test in interstitial lung disease and pulmonary hypertension in scleroderma.
Garin MC; Highland KB; Silver RM; Strange C
J Rheumatol; 2009 Feb; 36(2):330-6. PubMed ID: 19208563
[TBL] [Abstract][Full Text] [Related]
13. Extra-pulmonary features in COPD patients entering rehabilitation after stratification for MRC dyspnea grade.
Spruit MA; Pennings HJ; Janssen PP; Does JD; Scroyen S; Akkermans MA; Mostert R; Wouters EF
Respir Med; 2007 Dec; 101(12):2454-63. PubMed ID: 17765532
[TBL] [Abstract][Full Text] [Related]
14. Volitional pursed lips breathing in patients with stable chronic obstructive pulmonary disease improves exercise capacity.
Bhatt SP; Luqman-Arafath TK; Gupta AK; Mohan A; Stoltzfus JC; Dey T; Nanda S; Guleria R
Chron Respir Dis; 2013 Feb; 10(1):5-10. PubMed ID: 23149383
[TBL] [Abstract][Full Text] [Related]
15. Locus of symptom limitation and exercise response to bronchodilation in chronic obstructive pulmonary disease.
Deschênes D; Pepin V; Saey D; LeBlanc P; Maltais F
J Cardiopulm Rehabil Prev; 2008; 28(3):208-14. PubMed ID: 18496322
[TBL] [Abstract][Full Text] [Related]
16. Daily functioning of dyspnea, self-esteem and physical self in patients with moderate COPD before, during and after a first inpatient rehabilitation program.
Ninot G; Moullec G; Desplan J; Prefaut C; Varray A
Disabil Rehabil; 2007 Nov; 29(22):1671-8. PubMed ID: 17852227
[TBL] [Abstract][Full Text] [Related]
17. Effects of inspiratory muscle thixotropy on the 6-min walk distance in COPD.
Izumizaki M; Satake M; Takahashi H; Sugawara K; Shioya T; Homma I
Respir Med; 2008 Jul; 102(7):970-7. PubMed ID: 18396028
[TBL] [Abstract][Full Text] [Related]
18. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
19. Dyspnea and activity limitation in COPD: mechanical factors.
O'Donnell DE; Laveneziana P
COPD; 2007 Sep; 4(3):225-36. PubMed ID: 17729066
[TBL] [Abstract][Full Text] [Related]
20. Six-minute walking test in cystic fibrosis adults with mild to moderate lung disease: comparison to healthy subjects.
Chetta A; Pisi G; Zanini A; Foresi A; Grzincich GL; Aiello M; Battistini A; Olivieri D
Respir Med; 2001 Dec; 95(12):986-91. PubMed ID: 11778797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
